Aphria Inc. is the newest weed company to graduate to the TSX. The stock has been faring better than its peers, Canopy Growth Corp. and Aurora Cannabis Inc. over the past few months.
Beyond the legal issues, the problem for investors is that the industry is filled with small publicly traded companies that are risky bets at best, and outright fraudulent at worst.
Legal marijuana flat-Earthers, like U.S. Attorney General Jeff Sessions, have tried many methods to discredit breakthroughs in medical cannabis, but these efforts at discrediting cannabis stop at the U.S. border.
Marijuana has quickly become the next “can’t miss” investing idea for investors across North America. Despite this huge potential market, people are reluctant to put any of their cash into this market
There are a number of big institutions, including mutual funds, pension funds, and investment banks, that use the TSX Composite and its sub-indices as performance benchmarks for their portfolios. The addition of Canopy to the index will introduce some new dimensions to the index’s performance.
The cannabis industry’s excitement is building as the California takes steps towards establishing its legal recreational market. This week Los Angeles voters approved Measure M to create regulations for adult-use marijuana, thus setting up the city to steal the title of marijuana capital from Denver.
An industry previously only regulated by law enforcement leaves tremendous uncertainty for those looking to get into the industry from an investment perspective. Organizations like MJIC are stepping up to provide regulatory support and protection for marijuana operators.
While it is still difficult to invest directly in legal pot through public equities, venture capital firms and private equity funds have raised hundreds of millions of investment dollars.
Proceed with caution, said a number of speakers taking part in the California Cannabis Business Expo, which runs through Wednesday at the San Diego Sheraton Hotel and Marina.
Advocates, investors and entrepreneurs believe that the profile of marijuana users will change now that cannabis is legal. They all have one thing in common — wanting to make money from the new cannabis consumer.
Investors in cannabis companies had an eventful 2016 with the approval of recreational marijuana usage in the states of California, Massachusetts, Maine, and Nevada providing a boost to all sorts of marijuana stocks. Of particular note, shares of Corbus Pharmaceuticals (NASDAQ: CRBP) posted a whopping 600% gain in 2016 following positive phase 2 data.
Canopy Growth’s recently acquired Mettrum Ltd. stated that it wrote off $800,000 of costs owing to a series of recalls over the use of a banned pesticides. The staff at Mettrum feared detection from authorities, so they hid the pesticides in the office’s ceiling tiles.
Over the next five years, the U.S. marijuana market could be worth tens of billions of dollars, and according to GreenWave Advisors, LLC, these five states could move the needle most for marijuana companies. Learn just how big the marijuana market may be in California, Washington, Pennsylvania, Colorado, and Michigan in 2021.
The cannabis industry is expected to reach $50 billion in size by 2026, according to Cowen & Co., making it one of the fastest growing industries in the world. Investors have taken a growing interest in the industry as legalization has spread across North America. Here are three subsets of the cannabis industry that investors may want to consider for the best risk-adjusted returns.
Investors are incredibly excited about Canopy Growth Corporation. But we’re now looking at a situation where the stock has increased quite aggressively thanks mostly to the belief that the future is bright. And there are still many investors sitting on the sidelines wondering if they should consider this company.
On the face of it, 2017 may be the year to jump into the marijuana market to get a piece of what looks to be promising growth over the next few years.
Chris Blake, Senior Portfolio Manager, TD Wealth, explains what investors need to know before buying marijuana stocks.
Florida is undeniably behind the curve when it comes to passing pro-pot legislation, but the Sunshine State did make up some ground in November, when voters legalized medical marijuana in the state. How big could the medical marijuana market be in Florida for marijuana stocks?
Forward-thinking investors are already plotting seven-figure weed windfalls with the top pot stocks from every ecosystem. You see, there’s more to the marijuana industry than just selling cannabis. There are a lot of ways to profit from legal recreational and medical marijuana sales.
Investing in cannabis stocks is being called the “gold rush” of the 21st century. That’s because legal marijuana sales in North America climbed to $6.7 billion in 2016.
Sales in the legal marijuana industry are skyrocketing, which is why Money Morning created a list of the top marijuana stocks to watch in 2017. But because marijuana is still illegal under federal law, and many of the marijuana stocks on the market are so volatile, this isn’t a list of recommendations. Rather, it’s a list of marijuana stocks they are watching closely in 2017.
Most myths have at least a little bit of truth interspersed with a lot that is false. That’s the case with these three myths about marijuana stocks that some might mistakenly believe.
If you’re considering investing in marijuana stocks in the new year, here are five numbers you should know before taking the plunge.
Are you an entrepreneur eager to fund your cannabis business? Needless to say, banks are not going to be your first choice. How can you raise capital legally and then bank the money you make?
On Sept. 12, 2016, Cowen and Company (Nasdaq:COWN) released a report on the near- and long-term market potential of legal recreational cannabis in the United States, estimating that a federally legal U.S. cannabis market could reach $50 billion in gross retail sales by 2026.
It’s no longer a secret that the cannabis industry is growing in a big way. In a remarkably short amount of time, cannabis has already been fully legalized in five states.
So many people get tripped up or freaked out about the idea of investing in the cannabis industry, as if it is somehow a foreign concept, when in actuality many of the investment opportunities in the cannabis space have an interesting and financially sound platforms to their business models.
An effective executive summary gives a brief, high-level overview of your business, the financing that you are seeking, and it should pique the interest of decision makers.
Here are three additional mistakes I see occurring frequently as business owners look for financing. Steer clear of these pitfalls and you will dramatically increase your chances for success.
Many companies directly in or serving the cannabis industry have turned to the public markets in order to facilitate raising capital.
As a veteran in commercial financing for marijuana businesses, I have seen many business owners struggle to obtain funding.
The marijuana industry may be growing rapidly, but if you don’t know these critical points, your investment in marijuana stocks could go up in smoke.
While investment in cannabis industries is limited in the U.S. by federal law, Canadian companies and investors don’t face these same restrictions.
Interested in taking part of Oregon’s upcoming recreational marijuana market? While the entry barriers for dispensaries in Oregon aren’t as high they are in other states, it still takes a sizable investment to enter the business. And to get funding, companies must be prepared.
On Nov. 12, 2015, the Colorado Division of Securities issued an investor alert titled, “Are you an Informed Investor? The Next Big Thing.” The alert addressed the popularity of investments in marijuana, binary options and digital currencies.
Randy Shipley, the founder and CEO of CannaFundr.com, is among those who believe that the new SEC rules will “potentially” have a positive influence on the marijuana industry.
Cannabis is in a unique situation of potential exponential growth both from the financial standpoint and the research and development standpoint, but has to trade in a market place with a dubious reputation.
On July 9, 2015, the Securities and Exchange Commission announced that it had settled charges against Alexander Hawatmeh and Christopher Mrowca. So far, so good, but is the legal marijuana industry any safer for investors?
Always on the lookout for ways investors are participating the cannabis space, today we are taking a look at a publicly traded company that, on the surface, offers a unique access point.
If you can forgive the rather liberal stretching of the analogy here, there are a lot of correlations between cannabis as an industry and this key stage of human development.
Would you like to invest in Uber? Or how about Airbnb? Well it turns out that you can’t. If you’re a regular Joe or Jane investor, there are no shares to buy for either company, or for companies like Pinterest and SpaceX.
Starting a new business is complicated enough – company founders have to find a place to set up shop, hire great employees, manage cash flow, market their goods or services and sometimes hire experts to help.
Quotations can connect you to wisdom from the past that you can apply to the present and the future. Many of the legal marijuana industry’s key players have already amassed vital wisdom during the industry’s fledgling years.
Ever since the SEC cracked down on marijuana-related investments in 2014, potential investors have been painfully aware of the need to conduct adequate due diligence on the early-stage companies that come courting.
More than 115 early-stage startups applied for one of 10 spots within CanopyBoulder’s spring business accelerator program for the legal cannabis industry.
Public stock investors in the cannabis industry are largely relegated to the over-the-counter marketplace. This is much different from stocks trading on an exchange, and far less expensive for companies to access.
Even in the wake of warnings from the SEC regarding fraudulent marijuana stocks, investors are still seeking ways to capitalize on the “green rush.”
Given the title of yesterday’s Market Musings piece and the subject of today’s, you, dear reader, could be forgiven for thinking that I have some kind of a drug problem. I can assure you that I don’t. I just have a problem with some drug stocks, both the non-conventional and more traditional.
Canada’s securities watchdogs are warning investors to be wary of publicly traded companies with ambitions to grow and sell medical marijuana after a rush of at least 13 firms into the industry.
Following its transfer to droop a fifth microcap firm that claims to be engaged within the rising marijuana business, U.S. securities regulators issued a warning to investors about the danger of fraud within the area. Proper information regarding trade within the marijuana sector may be withheld from hungry investors, the SEC warns. VIEW FULL ARTICLE